Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor

• US 5,173,295 A
• Filed: 10/05/1990
• Issued: 12/22/1992
• Est. Priority Date: 10/05/1990
• Status: Expired due to Fees

• Current Assignee: Advance Biofactures Corp. (Endo International PLC)
• Original Assignee: Advance Biofactures of Curacao, N.V. (Endo International PLC)
• Inventors: Wehling, Peter
• Primary Examiner(s): Robinson, Douglas W.
• Assistant Examiner(s): Witz, Jean C.
• Application Number:
  US07/593,778
• Time in Patent Office: 809 Days
• Field of Search: 424/94.67
• US Class Current: 424/94.67
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 38/4886 Metalloendopeptidases (3.4.24), e.g. collagenase
• CPC Class Codes: A61L 2300/254 Enzymes, proenzymes
• CPC Class Codes: A61L 24/0015 Medicaments; Biocides
• CPC Class Codes: A61L 24/106 Fibrin; Fibrinogen

Abstract

The regeneration of injured nerves is enhanced by supplying collagenase to the zone of injury of the nerve. Growth of nerve sprouts over the zone of injury is aided by the presence of effective amounts of collagenase during the regeneration process. If the nerve has been severed, collagenase is supplied to the ends of the proximal and distal stumps. A nerve graft may be interposed between the stumps. Natural fibrin has been used as glue to join nerve stumps, and collagenase is effective when used in admixture with fibrin.

Claims

1. A method of enhancing the regeneration of injured nerves which comprises administering an effective amount of collagenase to the zone of injury of the nerve during the regeneration process.

2. A method according to claim 1 wherein the nerve has been severed and collagenase is administered to the ends of the proximal and distal stumps.

3. A method according to claim 2 wherein fibrin containing collagenase is used as adhesive for the stumps.

4. A method according to claim 3 wherein the ends are sutured.

5. A method according to claim 4 wherein the sutured region is coated with a fibrin and collagenase mixture.

6. A method according to claim 1 wherein injury has resulted in neuroma in continuity.

7. A method according to claim 1 wherein the stumps of individual served fascicles of fascicle groups are separately co-apted.

8. A method according to claim 2 wherein a nerve graft is interposed between the stumps.

9. A method according to claim 8 wherein interfascicular nerve grafts are employed.

10. A method according to claim 1 wherein collagenase is supplied in a pharmaceutically acceptable medium containing about 200 to 2,500 ABC units of collagenase/ml.

11. A method according to claim 10 wherein the medium comprises normal saline.

12. A method according to claim 1 wherein collagenase is supplied in a pharmaceutically acceptable medium containing about 500 to 1,000 ABC units of collagenase/ml.